BRIEF-Cynapsus says Sunovion Pharma entitled to termination fee of $24 mln if deal terminated - SEC filing

Thu Sep 1, 2016 7:31am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Sept 1 (Reuters) - Cynapsus Therapeutics

* Sunovion Pharma entitled to termination fee in amount of $24 million which shall be paid by co if deal terminated - SEC filing Source: (bit.ly/2bT5Y0k ) Further company coverage: